(CAS) Cascades - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA1469001053

CAS: Packaging, Tissue, Containerboard, Boxboards, Papers

Cascades Inc. is a leader in the packaging and tissue products industry, operating primarily in Canada and the United States. Founded in 1964 and headquartered in Kingsey Falls, Canada, the company has established itself as a significant player in sustainable packaging solutions. Cascades specializes in producing, converting, and marketing products made from recycled fibers, which not only aligns with environmental sustainability trends but also appeals to eco-conscious consumers and investors focused on ESG factors.

The company operates through three distinct segments: Containerboard, Specialty Products, and Tissue Papers. The Containerboard segment produces essential packaging materials, catering to industries that require robust and reliable packaging solutions. This segment is crucial as packaging demand remains consistent across various sectors. The Specialty Products segment offers niche solutions, such as uncoated recycled boxboards, diversifying the companys revenue streams and addressing specific market needs. The Tissue Papers segment provides staple products, ensuring a steady market presence due to consistent consumer demand.

Cascades commitment to sustainability is evident through its recovery and recycling activities, which contribute to a closed-loop production process. This approach not only enhances environmental efficiency but also supports cost management and margin maintenance, appealing to investors seeking both sustainability and financial performance.

From a financial perspective, Cascades has a market capitalization of approximately 1.3 billion CAD. The price-to-book (P/B) ratio of 0.76 may indicate undervaluation, suggesting potential for investors. The price-to-sales (P/S) ratio of 0.28 highlights efficient revenue generation per share. With a forward price-to-earnings (P/E) ratio of 8.37, the company presents a balanced outlook, combining current stability with future growth expectations. These metrics position Cascades as an attractive option for investors seeking exposure to the packaging and tissue products sector with a focus on sustainability and operational efficiency.

Additional Sources for CAS Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

CAS Stock Overview

Market Cap in USD 836m
Sector Consumer Cyclical
Industry Packaging & Containers
GiC Sub-Industry Paper & Plastic Packaging Products & Materials
IPO / Inception

CAS Stock Ratings

Growth 5y 11.3%
Fundamental -20.2%
Dividend 70.9%
Rel. Strength Industry -22.6
Analysts -
Fair Price Momentum 10.69 CAD
Fair Price DCF 38.80 CAD

CAS Dividends

Dividend Yield 12m 4.43%
Yield on Cost 5y 5.11%
Annual Growth 5y 8.45%
Payout Consistency 96.0%

CAS Growth Ratios

Growth Correlation 3m 58.4%
Growth Correlation 12m 73.1%
Growth Correlation 5y -35.2%
CAGR 5y 4.01%
CAGR/Max DD 5y 0.08
Sharpe Ratio 12m 0.40
Alpha -6.02
Beta 0.87
Volatility 28.95%
Current Volume 278.4k
Average Volume 20d 302.8k
What is the price of CAS stocks?
As of February 22, 2025, the stock is trading at CAD 11.44 with a total of 278,435 shares traded.
Over the past week, the price has changed by -10.90%, over one month by -9.92%, over three months by +2.60% and over the past year by -18.83%.
Is Cascades a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Cascades is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -20.20 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CAS as of February 2025 is 10.69. This means that CAS is currently overvalued and has a potential downside of -6.56%.
Is CAS a buy, sell or hold?
Cascades has no consensus analysts rating.
What are the forecast for CAS stock price target?
According to ValueRays Forecast Model, CAS Cascades will be worth about 11.8 in February 2026. The stock is currently trading at 11.44. This means that the stock has a potential upside of +3.06%.
Issuer Forecast Upside
Wallstreet Target Price 14.1 23.1%
Analysts Target Price - -
ValueRay Target Price 11.8 3.1%